Biomarkers that can risk‐stratify children with influenza virus lower respiratory infection may identify patients for targeted intervention. Early elevation of alveolar‐related proteins in the bloodstream in these patients could indicate… Click to show full abstract
Biomarkers that can risk‐stratify children with influenza virus lower respiratory infection may identify patients for targeted intervention. Early elevation of alveolar‐related proteins in the bloodstream in these patients could indicate more severe lung damage portending worse outcomes.
               
Click one of the above tabs to view related content.